异常甲基化在异常性肺纤维化中的SPARC:一项探索性研究
Federico Pio Fabrizio1,2, Angelo Sparaneo1, Flavia Centra1
1Laboratory of Oncology, Fondazione IRCCS Casa Sollievo della Sofferenza, San GiovanniRotondo, Italy.
Frontiers in cell and developmental biology
|September 19, 2025
概括
被分泌的蛋白酸性和富含氨酸 (SPARC) 基因的异常促进子甲基化与异常性肺纤维化 (IPF) 有关. 这一发现表明SPARC甲基化可能成为IPF诊断的潜在分子标记物.
科学领域:
- 肺部医学 肺部医学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 异常性肺纤维化 (IPF) 是一种慢性间歇性肺病 (ILD),以渐进性纤维化为标志.
- 分泌的蛋白酸性和丰富的氨酸 (SPARC) 沉默与IPF病原体有关,但机制尚不清楚.
研究的目的:
- 调查异常促进子甲基化作为IPF中SPARC放松管制的机制.
- 评估SPARC促进剂甲基化作为IPF的潜在诊断标志物.
主要方法:
- 分析了44名IPF患者和23名非IPF对照组的甲固定嵌 (FFPE) 组织.
- 在11个CPG上使用定量甲基化特异PCR (QMSP) 评估SPARC促进者的DNA甲基化.
- 在体外实验中对纤维化和非纤维化细胞系进行了5-Aza-2'-deoxycytidine (5-Aza-CdR) 治疗.
主要成果:
- 与非IPF对照 (13%),相比,IPF样本中的SPARC促进物甲基化水平 (45%) 显著更高.
- 在接受治疗的纤维细胞中观察到SPARC mRNA水平和高甲基化之间的反相关性.
- 在治疗的非纤维细胞中没有观察到甲基化的显著变化.
结论:
- SPARC基因的促进子甲基化与IPF有关,但与非IPF无关.
- SPARC基因促进物甲基化可能代表IPF的潜在分子标记物.
- 在更大的队列中进行进一步的研究是有必要的,以验证这些发现.
相关概念视频
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:25Pulmonary Function Tests
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.